Association of APOE polymorphisms with disease severity in MS is limited to women.

Kantarci, O H; Hebrink, D D; Achenbach, S J; Pittock, S J; Altintas, A; Schaefer-Klein, J L; Atkinson, E J; De Andrade, M et al. · Neurology · 2004

prospective_cohort · Level II

Where this comes from

Abstract

The authors studied the association of an exon 4 (E4*epsilon2/3/4) and three promoter polymorphisms of APOE with disease course and severity stratified by gender in 221 patients with multiple sclerosis from two overlapping population-based prevalence cohorts. Women carriers of the E4*epsilon2 allele took longer to attain an Expanded Disability Status Scale score of 6 (p = 0.015) and had more favorable ranked severity scores than noncarriers (p = 0.009). There was no association in men. Alleles epsilon3 or epsilon4 and promoter polymorphisms were not associated with disease course or severity.

Medical subject headings